Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription Articles published in JAMA Retrieve available abstracts of 124 articles: HTML format

Single Articles

October 2025
1. ANDERER S
   As Measles Cases Climb in the Americas, Vaccination Urged.
   JAMA. 2025 Oct 10. doi: 10.1001/jama.2025.17493.
   PubMed    
   
   
   
2. LOTSCHER J, Walti CS, Heller S, Hengy Linder F, et al
   Respiratory Syncytial Virus Vaccination in Adult Allogeneic Hematopoietic Cell Transplant Recipients.
   JAMA. 2025 Oct 2:e2516744. doi: 10.1001/jama.2025.16744.
   PubMed    
   
   
   
3. VERMUND SH
   Potential Repercussions of Eliminating Mandatory Vaccination in Florida.
   JAMA. 2025 Oct 1. doi: 10.1001/jama.2025.19510.
   PubMed    
   
   
   
4. NAVIN MC, Ross LF
   America's Vaccine Policy Whiplash-Finding the Way Forward.
   JAMA. 2025 Oct 1. doi: 10.1001/jama.2025.19088.
   PubMed    
   
   
   September 2025
5. ANDERER S
   Updated COVID-19 Vaccine Generates Strong Immune Response.
   JAMA. 2025 Sep 26. doi: 10.1001/jama.2025.13887.
   PubMed    
   
   
   
6. ABBASI J
   GLP-1 Drugs in Heart Failure, beta-Blockers After MI, the Shingles Vaccine, and More From ESC 2025.
   JAMA. 2025 Sep 19. doi: 10.1001/jama.2025.15515.
   PubMed    
   
   
   
7. SCHNEIDER L
   New Vaccination Guidance for Adults With Heart Disease.
   JAMA. 2025 Sep 12. doi: 10.1001/jama.2025.13873.
   PubMed    
   
   
   
8. RUDMAN SPERGEL AK, Callendret B, Kostanyan L
   Influenza and COVID-19 Multicomponent Vaccine in Adults-Reply.
   JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12225.
   PubMed    
   
   
   
9. LIU Z, Zhang L, Jiang M
   Influenza and COVID-19 Multicomponent Vaccine in Adults.
   JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12222.
   PubMed    
   
   
   
10. ANDERER S
    Breaking From CDC, ACOG Continues Recommending COVID-19 Vaccine During Pregnancy.
    JAMA. 2025 Sep 5. doi: 10.1001/jama.2025.16943.
    PubMed    
    
    
    August 2025
11. LASSEN MCH, Johansen ND, Christensen SH, Aliabadi N, et al
    Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults: A Prespecified Analysis of the DAN-RSV Trial.
    JAMA. 2025 Aug 30:e2515405. doi: 10.1001/jama.2025.15405.
    PubMed     Abstract available
    
    
    
12. SURIE D, Self WH, Yuengling KA, Lauring AS, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons.
    JAMA. 2025 Aug 30:e2515896. doi: 10.1001/jama.2025.15896.
    PubMed     Abstract available
    
    
    
13. CHU HY, Murray AF
    Shot Through the Heart-Can RSV Vaccination Reduce Risk of Cardiovascular Outcomes?
    JAMA. 2025 Aug 30. doi: 10.1001/jama.2025.16705.
    PubMed    
    
    
    
14. ANDERER S
    HHS Ends mRNA Vaccine Development.
    JAMA. 2025 Aug 29. doi: 10.1001/jama.2025.11013.
    PubMed    
    
    
    
15. ANDERER S
    CDC: Kindergarten Vaccine Exemptions Rise.
    JAMA. 2025 Aug 29. doi: 10.1001/jama.2025.11015.
    PubMed    
    
    
    
16. KANTER GP, Mankowitz T, Lurie P
    Conflicts of Interest in Federal Vaccine Advisory Committees.
    JAMA. 2025 Aug 18:e2513245. doi: 10.1001/jama.2025.13245.
    PubMed    
    
    
    
17. ANDERER S
    COVID-19 Vaccines Averted 2.5 Million Deaths, Mostly Among Older Adults.
    JAMA. 2025 Aug 15. doi: 10.1001/jama.2025.11001.
    PubMed    
    
    
    
18. SCHNEIDER L
    Study: No Link Between Aluminum in Childhood Vaccines and Chronic Disorders.
    JAMA. 2025 Aug 8. doi: 10.1001/jama.2025.10992.
    PubMed    
    
    
    
19. RUBIN R
    SARS-CoV-2 Variants Challenge Surveillance Efforts and COVID-19 Vaccines.
    JAMA. 2025 Aug 1. doi: 10.1001/jama.2025.12273.
    PubMed    
    
    
    July 2025
20. SILVERMAN A, Walsh R, Santoro JD, Thomas K, et al
    Influenza-Associated Acute Necrotizing Encephalopathy in US Children.
    JAMA. 2025 Jul 30:e2511534. doi: 10.1001/jama.2025.11534.
    PubMed     Abstract available
    
    
    
21. SCHWEITZER K
    Is There a Norovirus Vaccine on the Horizon?
    JAMA. 2025 Jul 25. doi: 10.1001/jama.2025.10673.
    PubMed    
    
    
    
22. ANDERER S
    Global Childhood Vaccination Progress Has Stalled in Recent Decades.
    JAMA. 2025 Jul 18. doi: 10.1001/jama.2025.10333.
    PubMed    
    
    
    
23. PRASAD V, Makary MA
    US FDA Safety Labeling Change for mRNA COVID-19 Vaccines.
    JAMA. 2025 Jul 14. doi: 10.1001/jama.2025.12675.
    PubMed    
    
    
    
24. ANDERER S
    The Meningitis Vaccine Appears to Protect Against Gonorrhea-Scientists May Now Know Why.
    JAMA. 2025 Jul 2. doi: 10.1001/jama.2025.10102.
    PubMed    
    
    
    
25. MARKS KM, Kang M, Umbleja T, Cox A, et al
    HepB-CpG Vaccine in People With HIV and Prior Nonresponse to HBV Vaccine: The BEe-HIVe Trial End-of-Study Results.
    JAMA. 2025 Jul 2:e259894. doi: 10.1001/jama.2025.9894.
    PubMed    
    
    
    June 2025
26. GRUNEBAUM A, Chervenak FA
    Professional Responsibility for COVID-19 Vaccination in Pregnancy.
    JAMA. 2025 Jun 25. doi: 10.1001/jama.2025.11328.
    PubMed    
    
    
    
27. GOSTIN LO, Reiss D, Offit PA
    Changed Recommendations for COVID-19 Vaccines for Children and Pregnant Women: A Failure of Process, Policy, and Science.
    JAMA. 2025 Jun 13. doi: 10.1001/jama.2025.10658.
    PubMed    
    
    
    
28. ZETTLER PJ, Cha S, Despres S, Lurie P, et al
    FDA Review of Novavax's COVID-19 Vaccine-Regulatory Integrity and Deviations From Standard Practice.
    JAMA. 2025 Jun 9. doi: 10.1001/jama.2025.9898.
    PubMed    
    
    
    
29. PRASAD V, Kaslow DC, Yang S
    Pausing Chikungunya Vaccination and Accelerated Approval.
    JAMA. 2025 Jun 5. doi: 10.1001/jama.2025.9393.
    PubMed    
    
    
    
30. DONG E, Saiyed S, Nearchou A, Okura Y, et al
    Trends in County-Level MMR Vaccination Coverage in Children in the United States.
    JAMA. 2025 Jun 2:e258952. doi: 10.1001/jama.2025.8952.
    PubMed    
    
    
    May 2025
31. ANDERER S
    RSV Vaccine Shows Real-World Effectiveness in Older Adults.
    JAMA. 2025 May 30. doi: 10.1001/jama.2025.7762.
    PubMed    
    
    
    
32. KARABA AH, Segev DL, Werbel WA
    Respiratory Syncytial Virus Vaccination-Reply.
    JAMA. 2025 May 7. doi: 10.1001/jama.2025.2141.
    PubMed    
    
    
    
33. VICENTE-RABANEDA EF, Cardenoso-Domingo L, Castaneda S
    Respiratory Syncytial Virus Vaccination.
    JAMA. 2025 May 7. doi: 10.1001/jama.2025.2137.
    PubMed    
    
    
    
34. RUDMAN SPERGEL AK, Wu I, Deng W, Cardona J, et al
    Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults >/=50 Years: A Randomized Clinical Trial.
    JAMA. 2025 May 7:e255646. doi: 10.1001/jama.2025.5646.
    PubMed     Abstract available
    
    
    
35. ANDERER S
    Shingles Vaccine Linked to Lower Dementia Risk.
    JAMA. 2025 May 2. doi: 10.1001/jama.2025.5644.
    PubMed    
    
    
    April 2025
36. ANDERER S
    Childhood Vaccination Rates Still Lag Behind Prepandemic Levels.
    JAMA. 2025 Apr 25. doi: 10.1001/jama.2025.4675.
    PubMed    
    
    
    
37. KIANG MV, Bubar KM, Maldonado Y, Hotez PJ, et al
    Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the US.
    JAMA. 2025 Apr 24. doi: 10.1001/jama.2025.6495.
    PubMed     Abstract available
    
    
    
38. POMIRCHY M, Bommer C, Pradella F, Michalik F, et al
    Herpes Zoster Vaccination and Dementia Occurrence.
    JAMA. 2025 Apr 23:e255013. doi: 10.1001/jama.2025.5013.
    PubMed     Abstract available
    
    
    
39. O'LEARY ST
    Strategies for Communicating With Parents About Vaccines.
    JAMA. 2025 Apr 9. doi: 10.1001/jama.2025.4882.
    PubMed    
    
    
    
40. JACOBS JW, Booth GS
    Unreliable Vaccine Information and the Erosion of Science.
    JAMA. 2025 Apr 9. doi: 10.1001/jama.2025.5723.
    PubMed    
    
    
    
41. EDWARDS KM
    Approaches for MMR Vaccination During a Measles Outbreak and Evolving Domestic Attitudes.
    JAMA. 2025 Apr 9. doi: 10.1001/jama.2025.5679.
    PubMed    
    
    
    March 2025
42. OPEL DJ, O'Leary ST, Stockwell MS
    The Future of Research on Vaccine Uptake at the National Institutes of Health.
    JAMA. 2025 Mar 31. doi: 10.1001/jama.2025.4725.
    PubMed    
    
    
    
43. ANDERER S
    HPV Vaccine Cuts Cervical Precancer Incidence, but Rural Access Gaps Remain.
    JAMA. 2025 Mar 28. doi: 10.1001/jama.2025.2573.
    PubMed    
    
    
    
44. RADER B, Walensky RP, Rogers WS, Brownstein JS, et al
    Revising US MMR Vaccine Recommendations Amid Changing Domestic Risks.
    JAMA. 2025 Mar 14. doi: 10.1001/jama.2025.3867.
    PubMed    
    
    
    
45. SCHWEITZER K
    Amid Texas Measles Outbreak, Clinicians Struggle to Offset Increasing Vaccine Hesitancy.
    JAMA. 2025 Mar 14. doi: 10.1001/jama.2025.2932.
    PubMed    
    
    
    
46. LAURING AS, Edson C, Surie D, Dawood FS, et al
    Genomic Characterization of RSV in the US by Vaccination Status.
    JAMA. 2025 Mar 10. doi: 10.1001/jama.2025.1225.
    PubMed    
    
    
    
47. ANDERER S
    Sudan Virus Disease Outbreak in Uganda Spurs First-Ever Ebola Vaccine Trial.
    JAMA. 2025 Mar 7. doi: 10.1001/jama.2025.1347.
    PubMed    
    
    
    February 2025
48. ANDERER S
    FDA Issues Warning of Guillain-Barre Syndrome Risk for 2 RSV Vaccines.
    JAMA. 2025 Feb 21. doi: 10.1001/jama.2025.0545.
    PubMed    
    
    
    
49. WU PH, Ho YY, Chang CM
    Electronic Nudges for Influenza Vaccination.
    JAMA. 2025 Feb 10. doi: 10.1001/jama.2024.26532.
    PubMed    
    
    
    
50. JOHANSEN ND, Biering-Sorensen T
    Electronic Nudges for Influenza Vaccination-Reply.
    JAMA. 2025 Feb 10. doi: 10.1001/jama.2024.26535.
    PubMed    
    
    
    
51. EDWARDS KM
    Reflections on the Successes of Pediatric Vaccines.
    JAMA. 2025 Feb 6. doi: 10.1001/jama.2025.0865.
    PubMed    
    
    
    January 2025
52. CALIFF RM
    Consequences and Opportunities From Poor Uptake of COVID Vaccinations Despite Strong Evidence.
    JAMA. 2025 Jan 17. doi: 10.1001/jama.2025.0255.
    PubMed    
    
    
    December 2024
53. KARABA AH, Hage C, Sengsouk I, Balasubramanian P, et al
    Antibody Response to Respiratory Syncytial Virus Vaccination in Immunocompromised Persons.
    JAMA. 2024 Dec 30. doi: 10.1001/jama.2024.25395.
    PubMed    
    
    
    
54. ANDERER S
    Global Measles Cases Rose 20% in 1 Year as Vaccine Coverage Fell Short.
    JAMA. 2024 Dec 27. doi: 10.1001/jama.2024.25514.
    PubMed    
    
    
    
55. RUBIN R
    In Search of COVID-19 Vaccines That Elicit Mucosal Immunity and Stop Transmission.
    JAMA. 2024 Dec 20. doi: 10.1001/jama.2024.23627.
    PubMed    
    
    
    
56. ANDERER S
    Trial Shows It's Safe to Get COVID-19, Flu Vaccines at the Same Time.
    JAMA. 2024 Dec 13. doi: 10.1001/jama.2024.24891.
    PubMed    
    
    
    
57. ANDERER S
    CDC Recommends Lowering the Pneumococcal Vaccine Age to 50.
    JAMA. 2024 Dec 6. doi: 10.1001/jama.2024.24265.
    PubMed    
    
    
    
58. ANDERER S
    CDC Recommends Second COVID-19 Vaccine Dose for Older Adults.
    JAMA. 2024 Dec 6. doi: 10.1001/jama.2024.24258.
    PubMed    
    
    
    
59. MARKS KM, Kang M, Umbleja T, Cox A, et al
    HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial.
    JAMA. 2024 Dec 1:e2424490. doi: 10.1001/jama.2024.24490.
    PubMed     Abstract available
    
    
    
60. HUNG I, Lok AS
    Overcoming Hepatitis B Vaccine Nonresponsiveness.
    JAMA. 2024 Dec 1. doi: 10.1001/jama.2024.24028.
    PubMed    
    
    
    November 2024
61. ANDERER S
    Mpox Vaccine Appears Safe for Use in Adolescents.
    JAMA. 2024 Nov 22. doi: 10.1001/jama.2024.23619.
    PubMed    
    
    
    
62. PAN CQ, Dai E, Mo Z, Zhang H, et al
    Tenofovir and Hepatitis B Virus Transmission During Pregnancy: A Randomized Clinical Trial.
    JAMA. 2024 Nov 14. doi: 10.1001/jama.2024.22952.
    PubMed     Abstract available
    
    
    
63. ANDERER S
    WHO Approves Another HPV Vaccine for Single-Dose Use.
    JAMA. 2024 Nov 8. doi: 10.1001/jama.2024.22565.
    PubMed    
    
    
    October 2024
64. ANDERER S
    Study: MMR Vaccine Protection Wanes Slightly Over Time.
    JAMA. 2024 Oct 25. doi: 10.1001/jama.2024.21822.
    PubMed    
    
    
    
65. ANDERER S
    CDC Recommends Mpox Vaccine for Travelers to Central and Eastern Africa.
    JAMA. 2024 Oct 18. doi: 10.1001/jama.2024.21298.
    PubMed    
    
    
    
66. ANDERER S
    FDA Greenlights Nasal Spray Flu Vaccine for Use at Home.
    JAMA. 2024 Oct 18. doi: 10.1001/jama.2024.21299.
    PubMed    
    
    
    
67. RUBIN R
    Researchers Are Exploring the Role of Shingles-and a Protective Role of Shingles Vaccine-in Dementia.
    JAMA. 2024 Oct 18. doi: 10.1001/jama.2024.0227.
    PubMed    
    
    
    
68. TITANJI BK, Hazra A, Zucker J
    Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review.
    JAMA. 2024 Oct 14. doi: 10.1001/jama.2024.21091.
    PubMed     Abstract available
    
    
    
69. JOHANSEN ND, Vaduganathan M, Bhatt AS, Modin D, et al
    Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic Diseases: A Randomized Clinical Trial.
    JAMA. 2024 Oct 11. doi: 10.1001/jama.2024.21060.
    PubMed     Abstract available
    
    
    
70. ANDERER S
    Study: Single Dose of Modified Smallpox Vaccine Effective for Mpox.
    JAMA. 2024 Oct 11. doi: 10.1001/jama.2024.20120.
    PubMed    
    
    
    
71. COLLIER AY, McMahan K, Jacob-Dolan C, Liu J, et al
    Decline of Mpox Antibody Responses After Modified Vaccinia Ankara-Bavarian Nordic Vaccination.
    JAMA. 2024 Oct 3. doi: 10.1001/jama.2024.20951.
    PubMed    
    
    
    
72. RIVERS C, Watson C, Phelan AL
    The Resurgence of Mpox in Africa.
    JAMA. 2024;332:1045-1046.
    PubMed    
    
    
    September 2024
73. PARK S, Davis AM, Pillai AA
    Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma.
    JAMA. 2024;332:1013-1014.
    PubMed    
    
    
    
74. SCRUGGS-WODKOWSKI E, Malani P
    What Is Pertussis?
    JAMA. 2024;332:1030.
    PubMed    
    
    
    
75. ANDERER S
    FDA Approves Updated COVID-19 Vaccines.
    JAMA. 2024 Sep 20. doi: 10.1001/jama.2024.19127.
    PubMed    
    
    
    
76. HARRIS E
    As Mpox Cases Surge in Africa, WHO Declares a Global Emergency-Here's What to Know.
    JAMA. 2024;332:862-864.
    PubMed    
    
    
    
77. GOSTIN LO, Singaravelu S, Hynes N
    Smallpox Readiness: Modern Strategies Against an Ancient Disease.
    JAMA. 2024;332:873-874.
    PubMed    
    
    
    
78. ANDERER S
    Combo COVID-19 and Flu mRNA Vaccine Falls Short of Total Flu Protection.
    JAMA. 2024 Sep 13. doi: 10.1001/jama.2024.18194.
    PubMed    
    
    
    
79. ANDERER S
    Malaria Vaccine Candidate Could Prevent Infection During Pregnancy.
    JAMA. 2024 Sep 13. doi: 10.1001/jama.2024.18197.
    PubMed    
    
    
    
80. ANDERER S
    Promising Top-Line Results for RSV Vaccine in Immunocompromised Adults.
    JAMA. 2024 Sep 6. doi: 10.1001/jama.2024.17607.
    PubMed    
    
    
    
81. SURIE D, Self WH, Zhu Y, Yuengling KA, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults 60 Years and Older.
    JAMA. 2024 Sep 4:e2415775. doi: 10.1001/jama.2024.15775.
    PubMed    
    
    
    
82. GOODMAN JL, Bright RA, Lurie N
    H5 Influenza Vaccines-Moving Forward Against Pandemic Threats.
    JAMA. 2024 Sep 4. doi: 10.1001/jama.2024.17488.
    PubMed    
    
    
    August 2024
83. ANDERER S
    WHO Announces Project to Develop an mRNA H5N1 Vaccine for Humans.
    JAMA. 2024 Aug 30. doi: 10.1001/jama.2024.15887.
    PubMed    
    
    
    
84. SEMENZATO L, Le Vu S, Botton J, Bertrand M, et al
    Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies.
    JAMA. 2024 Aug 26:e2416380. doi: 10.1001/jama.2024.16380.
    PubMed     Abstract available
    
    
    
85. ANDERER S
    Current Shingles Vaccine Associated With Lower Risk of Dementia.
    JAMA. 2024 Aug 23. doi: 10.1001/jama.2024.15879.
    PubMed    
    
    
    
86. ANDERER S
    Vaccines Lowered Risk of Long COVID in US Veterans, but Not Completely.
    JAMA. 2024 Aug 16. doi: 10.1001/jama.2024.15518.
    PubMed    
    
    
    
87. HARRIS E
    NIH Starts Testing Nasal COVID-19 Vaccine in US.
    JAMA. 2024 Aug 2. doi: 10.1001/jama.2024.13769.
    PubMed    
    
    
    
88. COFFEY D
    The World Needs a Staph Vaccine-New Research Could Bring It a Step Closer.
    JAMA. 2024 Aug 2. doi: 10.1001/jama.2024.1015.
    PubMed    
    
    
    
89. HARRIS E
    Prenatal RSV Vaccine Not Tied to Higher Risk of Preterm Births.
    JAMA. 2024 Aug 2. doi: 10.1001/jama.2024.13773.
    PubMed    
    
    
    July 2024
90. HARRIS E
    CDC Revises RSV Vaccination Recommendation for Older Adults in US.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13385.
    PubMed    
    
    
    
91. HARRIS E
    COVID-19 Vaccination in Early Pregnancy Not Linked to Birth Defects.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13389.
    PubMed    
    
    
    
92. YOUMSHAJEKIAN L
    COVID-19 May Protect Against the Common Cold-Here's Why Knowing That Could Lead to Better Vaccines.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13382.
    PubMed    
    
    
    
93. AGARWAL SD, Cook BL, Liebman JB
    Effect of Cash Benefits on Health Care Utilization and Health: A Randomized Study.
    JAMA. 2024 Jul 22:e2413004. doi: 10.1001/jama.2024.13004.
    PubMed     Abstract available
    
    
    
94. HARRIS E
    Symptoms After COVID-19 Vaccination Tied to Higher Antibody Levels.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12231.
    PubMed    
    
    
    
95. RUBIN R
    Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.10992.
    PubMed    
    
    
    
96. 
    The Conquest of Yellow Fever.
    JAMA. 2024;332:175.
    PubMed    
    
    
    June 2024
97. HARRIS E
    WHO: As Mpox Outbreaks Continue, Cases May Be Underestimated.
    JAMA. 2024;331:2070.
    PubMed    
    
    
    
98. SCRUGGS-WODKOWSKI EA, Malani PN, Linder KA
    Therapies to Decrease Severe Respiratory Syncytial Virus Illness.
    JAMA. 2024;331:2127-2128.
    PubMed    
    
    
    
99. ZIMBROFF RM, Deardorff WJ, Song S, Nikolov MC, et al
    Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults.
    JAMA. 2024 Jun 20. doi: 10.1001/jama.2024.9673.
    PubMed    
    
    
    
100. DEAN N, Amin AB
     Test-Negative Study Designs for Evaluating Vaccine Effectiveness.
     JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.5633.
     PubMed    
     
     
     May 2024
101. HARRIS E
     Lower Dose of Mpox Vaccine Was Safe, Effective.
     JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
     PubMed    
     
     
     
102. HARRIS E
     Microneedle Vaccine Patches Generated Immune Response in Children.
     JAMA. 2024 May 24. doi: 10.1001/jama.2024.8629.
     PubMed    
     
     
     
103. QATO DM, Romley JA, Myerson R, Goldman D, et al
     Shingles Vaccination in Medicare Part D After Inflation Reduction Act Elimination of Cost Sharing.
     JAMA. 2024 May 23. doi: 10.1001/jama.2024.7348.
     PubMed    
     
     
     
104. HARRIS E
     CDC Warns of Surge in Meningococcal Disease in US.
     JAMA. 2024;331:1614.
     PubMed    
     
     
     
105. RUBIN R
     Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available.
     JAMA. 2024 May 17. doi: 10.1001/jama.2024.7370.
     PubMed    
     
     
     
106. HARRIS E
     National Academies Report: COVID-19 Vaccines Don't Cause Many Potential Harms.
     JAMA. 2024 May 10. doi: 10.1001/jama.2024.7724.
     PubMed    
     
     
     
107. HARRIS E
     Five-in-One Meningitis Vaccine Rolls Out.
     JAMA. 2024 May 10. doi: 10.1001/jama.2024.7727.
     PubMed    
     
     
     
108. AGRAWAL S, Ross JS, Ramachandran R
     Implications for Public Health Regulation if Chevron Deference Is Overturned.
     JAMA. 2024;331:1443-1444.
     PubMed    
     
     
     April 2024
109. ALLEN MR, Desai N, Namazi A, Leas E, et al
     Characteristics of X (Formerly Twitter) Community Notes Addressing COVID-19 Vaccine Misinformation.
     JAMA. 2024 Apr 24:e244800. doi: 10.1001/jama.2024.4800.
     PubMed    
     
     
     
110. VOELKER R
     What Is Hepatitis D Infection?
     JAMA. 2024 Apr 18. doi: 10.1001/jama.2024.1317.
     PubMed    
     
     
     
111. ANDERER S
     Could "Empathetic Refutation" Help Clinicians Sway Vaccine Skeptics?
     JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
     PubMed    
     
     
     
112. HARRIS E
     Measles Outbreaks in US and Abroad Prompt CDC Vaccination Alert.
     JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5153.
     PubMed    
     
     
     
113. HARRIS E
     COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
     JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
     PubMed    
     
     
     
114. HARRIS E
     Safety Concerns Put a Stop to Maternal RSV Vaccine Study.
     JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5155.
     PubMed    
     
     
     
115. DAWOOD FS, Payne AB, McMorrow ML
     Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus.
     JAMA. 2024 Apr 11. doi: 10.1001/jama.2024.5859.
     PubMed    
     
     
     March 2024
116. HARRIS E
     COVID-19 Infection Tied to Slight Cognitive Deficits.
     JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2087.
     PubMed    
     
     
     
117. EDWARDS KM, Griffin MR
     Postmarketing Vaccine Safety Assessments: Important Work in Progress.
     JAMA. 2024;331:915-917.
     PubMed    
     
     
     
118. LU Y, Matuska K, Nadimpalli G, Ma Y, et al
     Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults.
     JAMA. 2024;331:938-950.
     PubMed     Abstract available
     
     
     
119. HARRIS E
     WHO Issues First Recommendations for Managing Diphtheria.
     JAMA. 2024;331:907.
     PubMed    
     
     
     
120. ANDERER S
     CDC Recommends Additional COVID-19 Booster for Older Adults.
     JAMA. 2024 Mar 13. doi: 10.1001/jama.2024.2071.
     PubMed    
     
     
     
121. HARRIS E
     HPV Vaccination Rates Stagnated During COVID-19 Pandemic.
     JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1569.
     PubMed    
     
     
     February 2024
122. ANDERSSON NW, Thiesson EM, Hviid A
     Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
     JAMA. 2024 Feb 26:e241036. doi: 10.1001/jama.2024.1036.
     PubMed    
     
     
     
123. JAMIESON KH, Johnson KB, Cappola AR
     Misinformation and the Vaccine Adverse Event Reporting System.
     JAMA. 2024 Feb 26. doi: 10.1001/jama.2024.1757.
     PubMed    
     
     
     
124. HARRIS E
     New Prevention Guidance for Antibiotic-Resistant Meningococcal Cases.
     JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0731.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.